Stay updated on Nivolumab With Azacitidine in AML Clinical Trial

Sign up to get notified when there's something new on the Nivolumab With Azacitidine in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab With Azacitidine in AML Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.5.3 to v3.5.4, indicating a new release or update to the page’s underlying software. This change is administrative and does not modify the study content or visible details.
    Difference
    0.0%
    Check dated 2026-05-15T05:18:27.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page now lists the updated protocol revision v3.5.3, replacing the previous v3.5.2. This indicates a new version of the study protocol document.
    Difference
    0.0%
    Check dated 2026-04-30T18:35:51.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2 in the page metadata.
    Difference
    0.0%
    Check dated 2026-04-16T10:28:19.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.0%
    Check dated 2026-03-25T20:18:36.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The site revision has been updated to v3.4.3. The previous revision v3.4.2 has been removed.
    Difference
    0.0%
    Check dated 2026-03-11T14:44:30.000Z thumbnail image
  8. Check
    105 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed, replacing the older site-wide funding/status notice. No study content, eligibility criteria, or outcome measures were altered.
    Difference
    0.3%
    Check dated 2026-02-11T02:00:31.000Z thumbnail image

Stay in the know with updates to Nivolumab With Azacitidine in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab With Azacitidine in AML Clinical Trial page.